Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Travellers arriving from the United States enter a tent erected to perform the COVID-19 molecular test at one of five initial entry points, at the Douglas border crossing in Surrey, B.C., on March 13, 2021.


British Columbia will stop screening all positive COVID-19 tests for variants of concern, with medical experts saying the practice becomes less meaningful as variants drive case counts during the third wave of the pandemic, and one of them is poised to become the dominant source of infections in the province.

B.C. is now developing a strategy that will limit screening for variants largely to surveillance testing, which involves a sampling of the population, and will focus on health measures to prevent deaths and serious illness. It is expected to be implemented in coming weeks.

Mel Krajden, medical director of the BC Centre for Disease Control Public Health Laboratory, said it is unrealistic to stop the virus from spreading without “draconian” restrictions, and that efforts should instead be focused on protecting the population from their most serious harms.

Story continues below advertisement

“For us to believe that we are going to contain this by doing an additional test to say whether it’s a variant or not a variant is not realistic. It’s a false premise, in my mind,” he said.

“The important question is how well you are protected from these variants. And the best way to know that is … to do unbiased surveillance on what are the strains circulating in B.C. and how they are changing over time.”

Dr. Krajden said the province will still do whole genome sequencing for cluster identification, for travellers and to identify the source of infection in certain outbreaks.

“But when you do it in a random way [with surveillance testing], you’re really trying to sample to say, ‘Okay, what is circulating this week versus what circulated last week? Where are the hot spots? How do you support people? How do you vaccinate people quickly?’”

As of Wednesday, the province had confirmed a total of 3,766 COVID-19 cases that are variants of concern: 2,837 of the B.1.1.7 variant first detected in Britain, 878 cases of the P.1 variant first detected in Brazil and 51 cases of the B.1.351 variant first detected in South Africa. Of all variant cases, 266 are confirmed active, however this reported figure lags behind actual active cases. The B.1.1.7 variant is expected to become dominant in coming weeks.

Caroline Colijn, a mathematics professor and Canada Research Chair at Simon Fraser University, said the shift is logical given the limited sequencing capacity but that there are numerous advantages of screening all positive cases.

“If the question is: ‘Is it B.1.1.7?’ we know it’s likely going to be B.1.1.7 and we may not need to do sequencing 95 per cent of the time to [confirm] that,” she said.

Story continues below advertisement

“But if the question is: Where is our COVID coming from? What is the role of international borders? What is the role of interprovincial travel? Are we seeing introductions of other COVID? Those are all some of the roles of sequencing.”

Dr. Colijn said the shift will also necessitate reporting transparently not only on the number of variants detected but the number of tests screened.

“If they don’t say how many they tested or when they were from, then it’s like reading tea leaves,” she said.

Catalina Lopez-Correa, executive director of the Canadian COVID Genomics Network, said the collaboration for sequencing is working on an updated sampling strategy to ensure provinces properly align their sequencing efforts.

“Some regions are now doing more surveillance testing to get a better idea of the spread of these variants but we continue also to prioritize samples that we think are suspicious of having one of the variants of concern,” she said in an e-mail.

“SARS-CoV-2 Genome sequencing continues to be the gold standard to fully confirm the presence and evolution of the variants.”

Story continues below advertisement

On Tuesday, Provincial Health Officer Bonnie Henry spoke of “a whole landscape of these different viruses and different variants” that officials were monitoring, including the P.1 variant most commonly associated with Brazil.

Dr. Henry said it was likely that it was introduced to B.C. by visitors from other parts of Canada and then began circulating through several chains of transmission in the province. A “high percentage” is associated with Whistler, she said, where many visitors and staff members of the Whistler-Blackcomb ski resort have contracted the disease.

As of Tuesday, 197 cases of the P.1 variant were detected in Whistler, which had a total of 1,120 COVID-19 cases from Jan. 1 to March 28.

Dr. Henry said officials are monitoring whether the increasing prevalence of variants will have any impact on vaccine effectiveness and, to date, have not seen any notable impact.

The Provincial Health Officer also alluded to the upcoming shift in testing strategy.

“We need to use our surveillance resources – because we have a limited capacity to do whole genome sequencing – to focus on making sure we can detect if any other new variants that have some different mutation arise in the province as well,” she said. “That is part of what we will be focusing on in the coming weeks.”

Story continues below advertisement

With a report from Ivan Semeniuk

We have a weekly Western Canada newsletter written by our B.C. and Alberta bureau chiefs, providing a comprehensive package of the news you need to know about the region and its place in the issues facing Canada. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies